Related by context. All words. (Click for frequent words.) 77 Clolar 72 Clofarabine 71 tamibarotene 70 Amrubicin 69 Vidaza 69 TRISENOX 69 Velcade bortezomib 68 Clolar ® 68 Marqibo 68 Evoltra 68 YONDELIS 68 ixabepilone 68 Ceflatonin 67 Evoltra TM 67 pralatrexate 67 HuMax CD4 67 Dacogen 67 Evoltra R 67 Dacogen injection 66 Evoltra ® 66 ofatumumab 66 Mozobil 66 OPAXIO 66 Aplidin 66 FOLOTYN 66 registrational 66 Revlimid lenalidomide 66 Rituxan rituximab 66 satraplatin 65 lapatinib 65 Treanda 65 TEMODAL 65 perifosine 65 Angiox 65 Genasense 65 VIDAZA 65 romiplostim 65 Avastin bevacizumab 65 sunitinib malate 65 Troxatyl 65 deforolimus 65 trabectedin 65 Targretin 64 Azedra 64 AP# [003] 64 Jevtana 64 TREANDA 64 amrubicin 64 methylnaltrexone 64 Icatibant 64 MabThera 64 pomalidomide 64 MGCD# [001] 64 sapacitabine 64 VELCADE 64 YONDELIS R 64 Tarceva TM 64 carfilzomib 64 HGS# 64 Campath 64 Zavesca r 64 Velcade 64 mifamurtide 64 Folotyn 64 Mepact 64 REVLIMID 64 Raptiva ® 64 romidepsin 64 refractory chronic lymphocytic 64 VPRIV 64 Alemtuzumab 64 tesmilifene 64 Nimotuzumab 64 vemurafenib 64 relapsed multiple myeloma 64 MOZOBIL 64 JAK inhibitor 64 AEG# 63 BENLYSTA 63 Nexavar ® 63 BAY #-# 63 Torisel 63 Junovan 63 Allovectin 7 ® 63 Firazyr 63 EOquin 63 pitavastatin 63 PXD# 63 Ceplene 63 ADVEXIN 63 orphan designation 63 Phase Ib 63 Xcytrin 63 entinostat 63 ambrisentan 63 voclosporin 63 Annamycin 63 oral deforolimus 63 anticancer agent 63 ganetespib 63 MabCampath 63 Ixempra 63 phase IIb clinical 63 nimotuzumab 63 Campath ® 63 Tamibarotene 63 elotuzumab 63 ridaforolimus 63 Advexin 63 Civacir 63 Raptiva R 63 Amigal 63 azacitidine 63 Vasovist 63 Taxotere ® 62 Onconase 62 Yondelis 62 Vandetanib 62 alvimopan 62 Eribulin 62 omacetaxine 62 subcutaneous formulation 62 vandetanib 62 INCB# [001] 62 RG# [001] 62 Actemra tocilizumab 62 Urocidin 62 Abraxane 62 Promacta 62 depsipeptide 62 OvaRex ® MAb 62 Cloretazine R VNP#M 62 enzastaurin 62 Nexavar 62 Nexavar sorafenib 62 cutaneous T cell 62 Tarceva 62 Vectibix panitumumab 62 SYCREST 62 Perifosine 62 T DM1 62 Fodosine 62 monotherapy 62 HER2 positive metastatic breast 62 oncology indications 62 eltrombopag 62 diabetic neuropathic pain 62 VEGF Trap 62 Increlex ® 62 ASA# 62 Xanafide 62 maribavir 62 Onrigin 62 ONTAK 62 Cloretazine 62 Gleevec Glivec 62 radiation sensitizer 62 Orphan Drug status 62 Phase Ib study 62 TYZEKA 62 IMA# 62 docetaxel Taxotere R 62 Virulizin 62 HuLuc# 62 blinatumomab 62 Insegia 62 panitumumab 62 bendamustine 62 terlipressin 62 Tarceva erlotinib 62 neratinib 62 Phase III clinical 62 decitabine 62 dalbavancin 62 Hycamtin 62 axitinib 62 Revlimid 62 Pfizer Sutent 62 SNT MC# 62 BEXXAR 62 tanespimycin 62 Omacetaxine 62 Plicera 62 sorafenib Nexavar 62 EOquin TM 62 Allovectin 7 R 62 tocilizumab 62 bevacizumab Avastin 62 TORISEL 62 Actemra 62 Virulizin R 62 regadenoson 62 Loramyc R 62 IRESSA 62 bendamustine HCl 62 bortezomib Velcade R 62 Vectibix 62 Taxotere docetaxel 62 Erbitux cetuximab 61 Soliris TM eculizumab 61 dirucotide MBP# 61 Combidex 61 Phase 1b trial 61 Fludara 61 phase IIb trial 61 Mylotarg 61 TYKERB 61 Orphan Drug designation 61 Halaven 61 Genasense ® 61 temozolomide 61 Tracleer r 61 THALOMID 61 lintuzumab 61 FOLOTYN ® 61 MGd 61 phase IIa clinical 61 Tavocept 61 fenofibrate 61 Preotact 61 Phase Ib II 61 pixantrone 61 ONCASPAR 61 Allovectin 7 61 Herceptin trastuzumab 61 erlotinib Tarceva ® 61 Rebif ® 61 Neulasta R 61 application sNDA 61 Humira adalimumab 61 Bronchitol 61 temsirolimus 61 TELINTRA 61 ERBITUX 61 rilonacept 61 PDE4 inhibitor 61 Irinotecan 61 Camptosar 61 ONCONASE 61 silodosin 61 ATryn R 61 HUMIRA 61 sorafenib 61 ONGLYZA ™ 61 forodesine 61 metastatic hormone refractory 61 myelodysplastic syndromes MDS 61 alogliptin 61 brentuximab vedotin 61 orphan medicinal product 61 pediatric glioma 61 Pixantrone 61 daclizumab 61 Vilazodone 61 Zolinza 61 eniluracil 61 HGS ETR1 61 Carfilzomib 61 refractory Hodgkin lymphoma 61 vorinostat 61 Traficet EN 61 Modrenal R 61 ELACYT 61 Celgene Revlimid 61 Fludara ® 61 registrational trial 61 XYOTAX 61 otelixizumab 61 elesclomol 61 Lupuzor 61 zanolimumab 61 Loramyc 61 dirucotide 61 atacicept 61 PROMACTA 61 BCR ABL inhibitor 61 PREOS 61 Cloretazine ® 61 Neulasta ® 61 IL# PE#QQR 61 chronic lymphocytic leukemia CLL 61 Phase Ib clinical 61 REPLAGAL 61 Alzhemed TM 61 herpetic keratitis 61 Amplimexon 61 OMP designation 61 Actimmune ® 61 Zenvia ™ 60 tezampanel 60 ISTODAX 60 PhosLo 60 oral fludarabine 60 pertuzumab 60 Omnitarg 60 Sanofi Aventis Taxotere 60 IAP inhibitors 60 MyVax R 60 KNS # 60 confirmatory Phase III 60 HuMax CD# 60 alvespimycin 60 B CLL 60 albinterferon alfa 2b 60 lumiliximab 60 Multiferon R 60 Erbitux 60 apaziquone 60 dacetuzumab 60 incyclinide 60 velaglucerase alfa 60 lupus nephritis 60 Phase 2b trial 60 AQ4N 60 ISENTRESS 60 Alpharadin 60 Rescula 60 proteasome inhibitor 60 paclitaxel Taxol ® 60 Nplate 60 MEK inhibitors 60 Oxaliplatin 60 rALLy clinical trial 60 erlotinib 60 Arzerra ofatumumab 60 generation purine nucleoside 60 refractory APL 60 TELCYTA 60 golimumab 60 Fibrillex TM 60 Tyrima 60 hematologic malignancies 60 OHR/AVR# 60 ponatinib 60 taliglucerase alfa 60 Archexin 60 INCB# [002] 60 Arranon 60 IMC A# 60 EFAPROXYN 60 tivozanib 60 Telavancin 60 rNAPc2 60 L BLP# 60 indolent NHL 60 Orphan Drug Designation 60 oral ridaforolimus 60 Yondelis ® 60 Clevudine 60 Teflaro 60 GW# [003] 60 CytoFab 60 Preotact R 60 abiraterone acetate 60 Sebivo 60 Erlotinib 60 LAF# 60 ophthalmic indications 60 BYETTA ® 60 Defibrotide 60 Increlex 60 UPLYSO 60 ofatumumab HuMax CD# 60 Satraplatin 60 Dapagliflozin 60 IMiDs 60 Certican 60 NUVIGIL 60 NOXAFIL 60 IMGN# 60 StemEx R 60 Cethrin 60 obatoclax 60 Arzerra 60 ThermoDox ® 60 Campath alemtuzumab 60 RAPAFLO 60 vidofludimus 60 RoACTEMRA 60 CoFactor 60 Targretin capsules 60 vosaroxin 60 Tygacil 60 R sorafenib tablets 60 tesetaxel 60 PrevOnco 60 NXL# 60 ProLindac 60 voreloxin 60 Rituxan 60 Phase IIIb clinical 60 Angiox R 60 Solasia 60 RH1 60 Esbriet 60 TheraCIM 60 abatacept Orencia 60 OMAPRO 60 Plenaxis R 60 bardoxolone 60 investigational compound 60 relapsed ovarian cancer 60 receptor tyrosine kinase inhibitor 60 bevacizumab Avastin ® 60 valopicitabine 60 acyclovir Lauriad R 60 Biologics License Application 60 Genentech Roche 60 Arixtra 60 lubiprostone 60 Blinatumomab 60 StemEx 60 FAMPYRA 60 Aviptadil 60 metastatic renal cell carcinoma 60 Acute Myeloid Leukemia AML 60 reslizumab 60 Pixuvri 60 relapsing remitting multiple sclerosis 60 epothilone 60 sNDA 60 pediatric acute lymphoblastic 60 pegfilgrastim 60 mTOR inhibitor 60 thalidomide Thalomid 60 Silodosin 60 Tracleer R 59 Asentar 59 LEUKINE 59 Ceflatonin R 59 Pirfenidone 59 refractory multiple myeloma 59 sorafenib Nexavar ® 59 Nebido 59 eculizumab 59 Leukine 59 cetuximab Erbitux R 59 LHRH antagonist 59 Levulan PDT 59 Cimzia ® certolizumab pegol 59 Bortezomib 59 TRISENOX ® 59 XmAb# 59 Alimta 59 ezogabine 59 TEMODAR 59 mipomersen 59 ZEFTERA TM Zevtera TM 59 Teysuno 59 denosumab 59 ustekinumab 59 OncoVEX GM CSF 59 Navelbine ® 59 docetaxel 59 Cx# [002] 59 glufosfamide 59 Oncoscience AG 59 CHOP chemotherapy 59 BioNumerik 59 SEBIVO 59 Proxinium TM 59 elacytarabine 59 Peginterferon alfa 2b 59 phase Ib 59 MabThera Rituxan 59 anti TNF 59 L MTP PE 59 lomitapide 59 anticancer compound 59 refractory acute myeloid 59 regorafenib 59 hematological malignancies 59 Phase III randomized controlled 59 Xinlay 59 Loramyc ® 59 relapsed refractory multiple myeloma 59 ceftaroline 59 Vidaza azacitidine 59 Dacogen decitabine 59 BRIM3 59 JOULFERON 59 veltuzumab 59 Eloxatin ® 59 Intravenous CP 59 Replagal 59 REVLIMID lenalidomide 59 infusional 5-FU/LV 59 HCD# [002] 59 Panzem R NCD 59 Xyrem ® 59 goserelin 59 Canvaxin 59 Yervoy 59 HQK 59 sBLA 59 sunitinib 59 rheumatoid arthritis psoriatic arthritis 59 Cladribine Tablets 59 thymalfasin 59 ORENCIA R 59 Mipomersen 59 metastatic colorectal cancer 59 pivotal Phase III 59 advanced metastatic prostate 59 Behcet uveitis 59 Everolimus 59 ruxolitinib 59 StaphVAX 59 investigational therapies 59 Sutent sunitinib 59 efalizumab 59 palonosetron 59 sorafenib tablets 59 PrevOnco ™ 59 Cellegesic 59 Laquinimod 59 picoplatin 59 AVASTIN 59 gefitinib Iressa 59 Chrysalin 59 ATryn ® 59 Zalbin 59 low dose cytarabine 59 torezolid phosphate 59 pirfenidone 59 Gemzar 59 NEBIDO 59 CD# antibody [001] 59 Increlex R 59 Zerenex 59 PRT# 59 REMICADE infliximab 59 biologic therapy 59 potentially hepatotoxic 59 Simulect 59 Plenaxis TM 59 LY# [003] 59 CAELYX 59 Leukine ® 59 SPRYCEL ® 59 volociximab 59 relapsed refractory ALL 59 MAGE A3 ASCI 59 Pertuzumab 59 Neuradiab 59 Clavis Pharma 59 GED aPC 59 Zytiga 59 BRAF inhibitor 59 Panzem 59 panitumumab Vectibix 59 Sycrest 59 MEPACT 59 RoActemra 59 Degarelix 59 G CSF 59 refractory AML 59 docetaxel Taxotere ® 59 anti angiogenic therapy 59 paclitaxel Taxol R 59 anti leukemic 59 elinogrel 59 Mycamine 59 Azilect ® 59 adalimumab Humira 59 BRIM2 59 hematological cancers 59 Tostrex 59 cell chronic lymphocytic 59 galiximab 59 BCX# 59 Medicinal Products EMEA 59 Soliris eculizumab 59 talabostat 59 Reolysin 59 anticancer therapies 59 Oracea ® 59 registrational studies 59 Doxil 59 COPAXONE ® 59 tramiprosate ALZHEMED TM 59 Myocet 59 Orazol 59 Aclasta 59 Pazopanib 59 Ceflatonin ® 58 topical NSAID 58 Gleevec imatinib mesylate 58 Li Fraumeni Syndrome 58 Macugen 58 dose escalation Phase 58 teriflunomide 58 Marketing Authorization Application 58 vinorelbine 58 Zevalin 58 Gemzar ® 58 RITUXAN 58 Nabi HB Intravenous 58 lapatinib Tykerb 58 teduglutide 58 Sprycel 58 multiple myeloma 58 seliciclib CYC# 58 Alvesco R 58 visilizumab 58 Orphan Drug designations 58 CAMPATH 58 Cimzia ® 58 OXi# 58 diagnosed multiple myeloma 58 Imprime PGG 58 Filgrastim 58 ATL# [001] 58 TYGACIL 58 MAA submission 58 taxane 58 FTY# 58 ocrelizumab 58 DPP4 inhibitor 58 Eraxis 58 Phenoptin 58 Orathecin 58 bifeprunox 58 myelofibrosis 58 fidaxomicin 58 nebivolol 58 Visudyne R 58 Tanespimycin 58 orBec R 58 vascular disrupting agent 58 tremelimumab 58 GATTEX 58 anti EGFR antibody 58 dasatinib Sprycel 58 cinacalcet HCl 58 INTELENCE 58 AGGRASTAT ® 58 DAVANAT ® 58 GTC recombinant human 58 molecular entities NMEs 58 ANTEGREN 58 fipamezole 58 Afinitor 58 Symadex 58 multiple myeloma MM 58 Thalidomide Pharmion 58 Romidepsin 58 JAK inhibitors 58 refractory metastatic colorectal cancer 58 dasatinib 58 cell lymphoma CTCL 58 ACZ# 58 rituximab 58 Orphan Medicinal Product 58 SinuNase 58 orphan drug 58 PROSTVAC ® 58 etanercept Enbrel 58 tetrabenazine 58 ceftobiprole 58 erlotinib Tarceva 58 cetuximab Erbitux ® 58 gefitinib 58 myelodysplastic syndromes 58 Genz # 58 AnGes 58 Marketing Authorisation Application 58 Flutiform TM 58 vernakalant hydrochloride 58 Japanese Encephalitis vaccine 58 Phase III 58 luliconazole 58 OncoVEX 58 Clonicel 58 imatinib Gleevec ® 58 chronic ITP 58 CDP# 58 Pemetrexed 58 Fusilev 58 Phase III clinical trials 58 EndoTAG TM -1 58 PEG INTRON 58 Solesta 58 talactoferrin 58 ZEVALIN 58 Removab 58 Romiplostim 58 Helsinn Healthcare 58 OncoGel 58 PF # [001] 58 dasatinib Sprycel ® 58 bortezomib Velcade 58 ACTEMRA 58 ProSavin 58 maraviroc 58 Taxol paclitaxel 58 dose escalation trial 58 clinical trial 58 Voraxaze 58 paclitaxel poliglumex 58 Ranexa 58 Zelrix 58 Maraviroc 58 Thalomid ® 58 novel histone deacetylase 58 HSP# inhibitor 58 rituximab Rituxan 58 tyrosine kinase inhibitor 58 histamine dihydrochloride 58 FRDA 58 telaprevir 58 Telatinib 58 Voraxaze ™ 58 tramiprosate 58 COMFORT II 58 peginesatide 58 PD LID 58 advanced NSCLC 58 Oracea 58 HuMax EGFr 58 Bendamustine 58 Dasatinib 58 asenapine 58 Retacrit 58 nucleoside analogue 58 YERVOY 58 Zybrestat 58 Pegintron 58 Panzem R 58 Zactima 58 novel oral anticoagulant 58 Ganite R 58 ThermoDox R 58 histone deacetylase HDAC inhibitor 58 ularitide 58 PEG Interferon lambda 58 Taxotere R 58 HIV integrase inhibitor 58 bazedoxifene 58 SIMPONI 58 AZILECT ® 58 REYATAZ R 58 evaluating REVLIMID 58 Abstral 58 posaconazole 58 sumatriptan injection 58 LymphoStat B 58 NEUMUNE 58 abiraterone 58 Relistor 58 Onco TCS 58 Vicinium TM 58 MAXY G# 58 ABRAXANE 58 IIa trial 58 Bayer Nexavar 58 Kepivance 58 Ilaris 58 docetaxel chemotherapy 58 AZX# 58 omacetaxine mepesuccinate 58 Advagraf 58 investigational drug 58 FIRAZYR 58 Fabry Disease 58 proteasome inhibitors 58 DXL# 58 Granulocyte Colony Stimulating Factor 58 EGRIFTA TM 58 Junovan TM 58 Zensana TM 58 Oncaspar 58 UVIDEM 58 teplizumab 58 topotecan 58 mitogen activated ERK kinase 58 Cimzia 58 FavId 58 pulmonary arterial hypertension 58 RELISTOR ® 58 Rhucin R 58 non metastatic osteosarcoma 58 ospemifene 58 Ventavis 58 supplemental Biologics License Application 58 SUTENT ® 58 VALSTAR 58 Vorinostat 58 MBP# [001] 58 NPSP# 58 oral anticoagulant 58 Pralatrexate 58 highly selective adenosine 58 Virulizin ® 58 Genasense R 58 LUVENIQ 58 Phase IIb trial 58 peripheral neuropathic pain 58 dabigatran etexilate 58 Prestara 58 TAXUS Element Stent System 58 PREOS R 58 ELAPRASE 58 BLA filing 58 LUCASSIN 58 Phase III trials 58 belinostat 58 BENLYSTA ® 58 Rectogesic 58 Lenalidomide 58 Sorafenib 58 dextromethorphan quinidine 58 cutaneous T 58 epigenetic therapies 58 RSD# 58 Epoetin alfa 58 cytarabine 58 Rhucin 58 SUTENT 58 sorafenib Nexavar R 58 CHMP recommendation 58 XGEVA 58 Maribavir 57 Mimpara 57 docetaxel Taxotere 57 Gemcitabine 57 Orphan Status 57 ZADAXIN 57 thetreatment 57 Kyowa Hakko Kirin 57 induced macular edema 57 Ambrisentan 57 liprotamase 57 Certolizumab pegol 57 chemotherapeutic agent 57 Cimzia certolizumab pegol 57 unique alkylating agent 57 Omapro 57 EGFR expressing mCRC 57 INTEGRILIN 57 rFVIIIFc 57 aflibercept 57 Oncophage 57 ONSOLIS 57 TLR9 agonist 57 dacarbazine 57 gemcitabine chemotherapy 57 vilazodone 57 Saphris 57 Aryplase 57 Kevetrin ™ 57 metaglidasen 57 ZETIA 57 Voreloxin 57 XAGRID 57 MYLOTARG 57 trastuzumab Herceptin 57 Noxafil 57 HoFH 57 Cimzia TM 57 Tykerb lapatinib 57 post menopausal osteoporosis 57 SUCCEED trial 57 Fortigel 57 ZENPEP 57 Arcalyst 57 metastatic castration resistant 57 Santhera 57 Indaflex TM 57 MabThera rituximab 57 ROTATEQ 57 vinflunine 57 plus dexamethasone 57 Efient 57 Centralized Procedure 57 pivotal Phase 57 orally bioavailable 57 PROVIGIL 57 ALD# 57 XL# [003] 57 haematological malignancies 57 Cloretazine R 57 figitumumab 57 gastrointestinal stromal tumors GIST 57 lenalidomide Revlimid R 57 anti TNF alpha 57 APTIVUS 57 corticosteroid dexamethasone 57 metastatic melanoma 57 Gattex 57 tafamidis 57 Zingo TM 57 UCB Cimzia 57 Elesclomol 57 PLK1 SNALP 57 prGCD 57 cediranib 57 Rituxan MabThera 57 CEQ# 57 interferon gamma 1b 57 Aggrastat 57 relapsed SCLC 57 Keppra ® 57 targeting CD# 57 Bezielle 57 DC Bead 57 gastrointestinal stromal tumors 57 Xyotax 57 ZADAXIN ® 57 cladribine 57 Intuniv 57 Abatacept 57 crofelemer 57 ZOLINZA 57 Soliris 57 Aptivus 57 Shigamabs ® 57 Personalized Immunotherapy 57 untreated multiple myeloma 57 Æterna Zentaris 57 Specifid 57 Joulferon 57 forodesine hydrochloride 57 Factor Xa inhibitor 57 Gleevec resistant 57 OPAXIO TM 57 Avastin 57 DOXIL 57 MEK inhibitor 57 RhuDex ® 57 faropenem 57 Aflibercept 57 ecallantide 57 IV Busulfex 57 ENMD # 57 #D#C# 57 drug ISA# 57 Fx #A 57 MK #B 57 Zavesca R 57 Vidaza R 57 Benlysta belimumab 57 cetrorelix 57 DU #b 57 Ontak 57 darunavir 57 rilpivirine 57 recurrent ovarian cancer 57 Rituximab 57 PTK ZK 57 hoFH 57 FOSRENOL 57 liposomal formulation 57 Orphan Designation 57 phase IIb 57 IAP inhibitor 57 Mycograb 57 senicapoc 57 Desmoteplase 57 imatinib mesylate 57 randomized Phase 57 tubulin inhibitor 57 Phase III TRIST 57 iloperidone 57 Preos 57 Abilify aripiprazole 57 REMICADE ® 57 lasofoxifene 57 PI3K/Akt pathway inhibitor 57 Alkeran 57 ZYBRESTAT 57 Friedreich Ataxia FRDA 57 lymphoma CTCL 57 bevacizumab 57 Gencaro 57 Tykerb 57 miglustat 57 refractory CLL 57 JANUVIA 57 desvenlafaxine 57 Lovaza TM 57 Vion Pharmaceuticals 57 pradefovir 57 filgrastim 57 relapsed leukemia 57 Marketing Authorization 57 cetuximab Erbitux 57 CYT# 57 relapsing multiple sclerosis 57 Diabetic Macular Edema 57 Quinamed 57 ELIQUIS 57 echinocandin 57 Diamyd ® 57 HGS ETR2 57 GRN# 57 leukemia AML 57 oral antidiabetic 57 imetelstat